Crossmark Global Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $558K | Buy |
|
|||||
|
2025
Q2 | $340K | Buy |
|
|||||
|
2025
Q1 | $275K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $251K | Sell |
|
|||||
|
2024
Q2 | $223K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $204K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $211K | Sell |
|
|||||
|
2023
Q1 | $227K | Buy |
|
|||||
|
2022
Q4 | $244K | Sell |
|
|||||
|
2022
Q3 | $219K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $203K | Sell |
|
|||||
|
2018
Q1 | $282K | Sell |
|
|||||
|
2017
Q4 | $385K | Buy |
|
|||||
|
2017
Q3 | $349K | Buy |
|
|||||
|
2016
Q3 | $349K | Buy |
|